<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_4CQh3CD">Economic Evaluation of Blood Pressure Monitoring Techniques in Patients With Hypertension A Systematic Review</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Open Access. This is an open access article distributed under the terms of the CC-BY License.</p>
				</availability>
				<date type="published" when="2023-11-21">November 21, 2023</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Michelle</forename><forename type="middle">A</forename><surname>Hayek</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Department of Health Policy and Organization , School of Public Health , The University of Alabama at Birmingham , 1665 University Blvd , Birmingham , AL 35294 Population Informatics Lab ,</note>
								<orgName type="department" key="dep1">Department of Health Policy and Organization</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="laboratory">Population Informatics Lab</orgName>
								<orgName type="institution">The University of Alabama at Birmingham</orgName>
								<address>
									<addrLine>1665 University Blvd</addrLine>
									<postCode>35294</postCode>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD, MS, MPharm</roleName><forename type="first">Theodoros</forename><surname>Giannouchos</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Department of Health Policy and Organization , School of Public Health , The University of Alabama at Birmingham , 1665 University Blvd , Birmingham , AL 35294 Population Informatics Lab ,</note>
								<orgName type="department" key="dep1">Department of Health Policy and Organization</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="laboratory">Population Informatics Lab</orgName>
								<orgName type="institution">The University of Alabama at Birmingham</orgName>
								<address>
									<addrLine>1665 University Blvd</addrLine>
									<postCode>35294</postCode>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation">Department of Industrial and Systems Engineering , Texas A&amp;M University , College Station (Hayek) ; Department of Health Policy and Organization , School of Public Health , The University of Alabama at Birmingham (Giannouchos ); Department of Industrial and Systems Engineering , Texas</note>
								<orgName type="department" key="dep1">Department of Industrial and Systems Engineering</orgName>
								<orgName type="department" key="dep2">College Station (Hayek)</orgName>
								<orgName type="department" key="dep3">Department of Health Policy and Organization</orgName>
								<orgName type="department" key="dep4">School of Public Health</orgName>
								<orgName type="department" key="dep5">Department of Industrial and Systems Engineering</orgName>
								<orgName type="institution" key="instit1">Texas A&amp;M University</orgName>
								<orgName type="institution" key="instit2">The University of Alabama at Birmingham (Giannouchos</orgName>
								<orgName type="institution" key="instit3">Texas</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mark</forename><surname>Lawley</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Department of Health Policy and Organization , School of Public Health , The University of Alabama at Birmingham , 1665 University Blvd , Birmingham , AL 35294 Population Informatics Lab ,</note>
								<orgName type="department" key="dep1">Department of Health Policy and Organization</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="laboratory">Population Informatics Lab</orgName>
								<orgName type="institution">The University of Alabama at Birmingham</orgName>
								<address>
									<addrLine>1665 University Blvd</addrLine>
									<postCode>35294</postCode>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Hye-Chung</forename><surname>Kum</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Department of Health Policy and Organization , School of Public Health , The University of Alabama at Birmingham , 1665 University Blvd , Birmingham , AL 35294 Population Informatics Lab ,</note>
								<orgName type="department" key="dep1">Department of Health Policy and Organization</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="laboratory">Population Informatics Lab</orgName>
								<orgName type="institution">The University of Alabama at Birmingham</orgName>
								<address>
									<addrLine>1665 University Blvd</addrLine>
									<postCode>35294</postCode>
									<settlement>Birmingham</settlement>
									<region>AL</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_9UnmEU3">Economic Evaluation of Blood Pressure Monitoring Techniques in Patients With Hypertension A Systematic Review</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2023-11-21">November 21, 2023</date>
						</imprint>
					</monogr>
					<idno type="MD5">6E853BA9714611F28E42AC2D2ABB9EA2</idno>
					<idno type="DOI">10.1001/jamanetworkopen.2023.44372</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T07:07+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EhZapXP">IMPORTANCE</head><p xml:id="_FEcgQcW"><s xml:id="_WQP37aV">Blood pressure monitoring is critical to the timely diagnosis and treatment of hypertension.</s><s xml:id="_spYJA5U">At-home self-monitoring techniques are highly effective in managing high blood pressure; however, evidence regarding the cost-effectiveness of at-home self-monitoring compared with traditional monitoring in clinical settings remains unclear.</s><s xml:id="_RxvhUTP">OBJECTIVE To identify and synthesize published research examining the cost-effectiveness of at-home blood pressure self-monitoring relative to monitoring in a clinical setting among patients with hypertension.</s><s xml:id="_YGtVNyM">EVIDENCE REVIEW A systematic literature search of 5 databases (PubMed, MEDLINE, Embase, EconLit, and CINAHL) followed by a backward citation search was conducted in September 2022.</s></p><p xml:id="_N5M7vgQ"><s xml:id="_5VStKgw">Full-text, peer-reviewed articles in English including patients with high blood pressure (systolic blood pressure Ն130 mm Hg and diastolic blood pressure Ն80 mm Hg) at baseline were included.</s><s xml:id="_HHjDJ5Z">Data from studies comparing at-home self-monitoring with clinical-setting monitoring alternatives were extracted, and the outcomes of interest included incremental cost-effectiveness and cost-utility ratios.</s><s xml:id="_QW4J7mA">Non-peer-reviewed studies or studies with pregnant women and children were excluded.</s><s xml:id="_p6P4jXU">To ensure accuracy and reliability, 2 authors independently evaluated all articles for eligibility and extracted relevant data from the selected articles.</s></p><p xml:id="_ZKJWjzZ"><s xml:id="_VSnbkTh">FINDINGS Of 1607 articles identified from 5 databases, 16 studies met the inclusion criteria.</s><s xml:id="_rYmrCQ9">Most studies were conducted in the US (6 [40%]) and in the UK (6 [40%]), and almost all studies ( <ref type="formula">14</ref>[90%]) used a health care insurance system perspective to determine costs.</s><s xml:id="_c3vCwmY">Nearly half the studies used quality-adjusted life-years gained and cost per 1-mm Hg reduction in blood pressure as outcomes.</s><s xml:id="_dHf4wNS">Overall, at-home blood pressure monitoring (HBPM) was found to be more cost-effective than monitoring in a clinical setting, particularly over a minimum 10-year time horizon.</s><s xml:id="_2Mqc5uw">Among studies comparing HBPM alone vs 24-hour ambulatory blood pressure monitoring (ABPM) or HBPM combined with additional support or team-based care, the latter were found to be more costeffective.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pZxe8Vc">CONCLUSIONS AND RELEVANCE</head><p xml:id="_VmycRzT"><s xml:id="_mD9knUP">In this systematic review, at-home blood pressure selfmonitoring, particularly using automatic 24-hour continuous blood pressure measurements or combined with additional support or team-based care, demonstrated the potential to be costeffective long-term compared with care in the physical clinical setting and could thus be prioritized for patients with hypertension from a cost-effectiveness standpoint.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QrgncTg">Introduction</head><p xml:id="_UMuDEyV"><s xml:id="_Rhr6rPc">Hypertension is a significant risk factor for heart attack and stroke and a major cause of premature death. <ref type="bibr">1</ref> Globally, nearly 1.3 billion adults have hypertension, with estimated health care expenditures reaching up to $1 trillion over a 10-year period. <ref type="bibr" target="#b1">2</ref></s><s xml:id="_fwj6aX6">However, only approximately 20% of patients with hypertension have their blood pressure (BP) under control. <ref type="bibr">1</ref> While BP measurements have traditionally taken place in clinics under the supervision of health care professionals, there has been increasing interest in transitioning to more convenient methods at home that mitigate the burden placed on patients who require regular visits.</s><s xml:id="_ntWSQ35">Self-monitoring at home has emerged as an effective and more convenient approach in monitoring BP levels in comparison with blood pressure measurements taken at a clinic. <ref type="bibr" target="#b2">3</ref></s><s xml:id="_dUNXG5V">Beyond its convenience, this approach informs patients and clinicians about blood pressure changes throughout the day in real time and enables tailored treatment formulation and needed adjustments to mitigate adverse outcomes associated with high BP. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref></s><s xml:id="_8ac6re6">However, self-monitoring at home, particularly when combined with additional support and resources (ie, telehealth services, counseling, or collaboration across health care professionals) can also result in added costs to patients, clinicians, hospitals, health care systems, and insurers given the required training and the time spent by clinicians and patients to frequently monitor BP and adjust treatment plans. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref></s><s xml:id="_FmqMZjj">ltiple studies have explored the costs, benefits, and effects of at-home self-monitoring BP techniques compared with traditional BP measurement in clinical settings. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b7">8</ref></s><s xml:id="_jrB4XgA">However, to our knowledge, there is no systematic review of the available literature documenting the costeffectiveness of at-home self-monitoring BP techniques for patients with hypertension over the past decade.</s><s xml:id="_sbHj2ST">In this study, we aimed to systematically gather research findings in the existing literature and to identify whether self-monitoring blood pressure at home is more cost-effective than measuring blood pressure at the clinic.</s><s xml:id="_rmZEhUh">By presenting evidence on the comparative effectiveness of self-monitoring programs, clinicians, stakeholders, and patients can make more informed decisions about the added value of transitioning to self-monitoring BP programs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_egx2n6f">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Pcty2FD">Search Strategy</head><p xml:id="_8Sy696R"><s xml:id="_T6mdRjj">We followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and reporting guidelines for economic evaluations to conduct this study. <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref></s><s xml:id="_3V8NNun">0]<ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref> Five databases were searched (PubMed, CINAHL, MEDLINE, EconLite, and Embase) in September 2022 (eTable 1 in Supplement 1).</s><s xml:id="_ubyEXer">We further augmented the search using snowballing of references among selected papers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SdRHfpq">Study Selection</head><p xml:id="_T6AJhen"><s xml:id="_P3T6zb3">Inclusion criteria were established a priori as full-text, peer-reviewed articles in English language including patients with high BP (systolic BP Ն130 mm Hg; diastolic BP Ն80 mm Hg) at baseline without any restrictions on comorbidities.</s><s xml:id="_S7rHwtM">To ensure consistency in the study population, we excluded studies with pregnant women and children.</s><s xml:id="_vrbWzDF">All studies needed to include a comparative economic analysis between at-home BP self-monitoring (intervention) and traditional BP measurements in physical clinical settings (usual care).</s><s xml:id="_jsBWUws">The intervention included patients selfmonitoring their BP at home and transmitting measurements to a health care professional via any means (eg, electronically, short message service, or mail).</s><s xml:id="_4QvNTgK">At-home self-monitoring could involve either periodically taking readings, such as twice each morning and evening during the first week of every month <ref type="bibr" target="#b12">13</ref> or 3 times per week <ref type="bibr" target="#b13">14</ref> (referred to as at-home BP monitoring [HBPM]) or utilizing 24-hour continuous BP monitoring (referred to as ambulatory BP monitoring [ABPM]), which uses a portable device to automatically measure a patient's BP at regular intervals, such as every 20 to 30 minutes over a continuous period. <ref type="bibr" target="#b14">15</ref></s><s xml:id="_tqEa7H9">he self-monitoring intervention could also be combined with additional behavioral interventions, such as nurse-tailored behavioral interventions <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b15">16</ref> or additional pharmacist care. <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref></s><s xml:id="_w2Kzz96"><ref type="bibr" target="#b18">[19]</ref> No restrictions were placed on the type of clinician, health care setting, or additional interventions studied.</s><s xml:id="_JTm7cCF">The outcome measures included incremental cost-effectiveness ratios (ICERs) and incremental cost-utility ratios (ICURs). <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b19">20</ref></s><s xml:id="_sfVFZzX">These were obtained from studies conducting costeffectiveness analysis (CEA) or cost-utility analysis (CUA).</s><s xml:id="_evHnCWt">CEA is a method of comparing costs with respect to a health outcome measured in nonmonetary values, such as costs added per 1-mm Hg reduction in SBP. <ref type="bibr" target="#b20">21</ref></s><s xml:id="_VB8cCJc">CUA is a method often used interchangeably with CEA and measures the health outcomes using quality-adjusted life-years (QALYs).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Cqy8RgG">Data Analysis</head><p xml:id="_U9EwvpU"><s xml:id="_BxvqtAv">Two researchers (M.A.H. and T.G.) independently conducted a quality assessment using the Joanna Briggs Institute Critical Appraisal Checklist for Economic Evaluations <ref type="bibr" target="#b21">22</ref> to determine the inclusion of each study (eTable 2 in Supplement 1).</s><s xml:id="_WKu75rK">To ensure accuracy, once the included studies were finalized, data extraction was similarly conducted independently by two researchers using recommended guidelines. <ref type="bibr" target="#b8">9</ref></s><s xml:id="_4rKSvqr">The extracted data included various factors such as participants, study designs, interventions, diagnosis, methods, outcomes, costs, and cost-effectiveness estimates.</s><s xml:id="_J48ZnUT">Data analysis was conducted in Excel version 2309 (Microsoft Corp).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PBu9TVF">Results</head><p xml:id="_3BrxfFt"><s xml:id="_UVnuRaH">Initially, a total of 1607 articles were identified from the 5 databases, and after excluding 86 duplicates, 1521 articles were screened based on their title and abstract (eFigure in Supplement 1).</s><s xml:id="_qRVy2mf">Among these, 1483 articles were excluded for not meeting the inclusion criteria, resulting in 38 articles for full-text assessment.</s><s xml:id="_JjCQaZb">During full-text review, 17 articles were excluded.</s><s xml:id="_8srS7Md">Ten of those (59%) had no economic analysis, 4 (24%) included the intervention as self-monitoring but not in a homebased-setting, and 3 (18%) were excluded based on quality assessment criteria (eTable 2 in Supplement 1).</s><s xml:id="_7ngaHJW">To supplement the search, we then reviewed the references of the 21 identified final articles.</s><s xml:id="_TZjUp6P">This led to the identification of 31 other articles, of which 28 did not meet the title and abstract inclusion criteria.</s><s xml:id="_8aNJpsn">Based on full text review, 3 articles identified from references were added to the original set, resulting in a total of 24 articles <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref> representing 16 distinct studies (eFigure in Supplement 1).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sThAGKd">Study Quality Assessment Criteria</head><p xml:id="_a88ZdTy"><s xml:id="_NZ6n34j">All of the included studies had a well-defined question and a comprehensive description of alternatives. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref></s><s xml:id="_Fmk77Qk">,<ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> Overall, 14 (88%) reported all relevant costs and outcomes for each alternative identified, <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b29">30</ref> and all studies established clinical effectiveness. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref></s><s xml:id="_eeXezyf">16]<ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> Most studies (13 [81%]) adequately described costs and outcomes, acknowledged limitations, and addressed concerns regarding the accuracy of the measurements.</s><s xml:id="_bjCcaCn"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b29">30</ref> Similarly, 12 studies (75%) provided sufficient explanations about how costs and outcomes were measured.</s><s xml:id="_d2rGQ9c"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b29">30</ref> Differential timing was taken into account in all of the studies. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref></s><s xml:id="_u6bQ4hK">,<ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> An incremental analysis of costs and outcomes was conducted in 15 studies (94%).</s><s xml:id="_tuQCwjW"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> A sensitivity analysis was conducted in 15 studies (94%).</s><s xml:id="_Ten5dS7"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> The majority of the studies provided a comprehensive assessment of the costeffectiveness of the intervention over the control.</s><s xml:id="_kgYvAQX"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> All of the studies adequately described the study setting and discussed the issue of generalizing the results to a different setting with similar characteristics.</s><s xml:id="_Uk9NDwa"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> interventions were compared with usual care (UC).</s><s xml:id="_R3c2hNT">The definition of usual care had minor differences but was generally considered as patients monitored per usual clinical care from their clinician without self-BP monitoring.</s><s xml:id="_Bv9fNfa"><ref type="bibr" target="#b30">31</ref> All articles included an intervention in which patients self-measured their BP at home using an electronic device and transferred their BP results to clinicians at a different location (ie, HBPM).</s><s xml:id="_XTYkCzs">HBPM was classified into 3 categories 37 : HBPM alone, HBPM with additional support (eg, basic website, online patient portals, or telephone consultations with clinicians or nurses <ref type="bibr" target="#b16">17</ref> ), and HBPM within team-based care (TBC), which involved more labor-intensive efforts, often combined with other behavioral interventions, such as pharmacist care <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref> or nurse behavioral interventions. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b15">16</ref> Blood pressure measured</s><s xml:id="_bH6mnx6">over a continuous 24-hour period was referred to as ABPM <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref> (Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_FCAtRME"><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref> Detailed characteristics of each article can be found in Table <ref type="table" target="#tab_1">2</ref>. Seven articles reported the comparison of more than 1 intervention, <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref> of which 4 included ABPM <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref> (Table <ref type="table" target="#tab_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KXtGyKh">Economic Analysis</head><p xml:id="_f3TNxX2"><s xml:id="_Kb3uesh">Among the 16 studies, 7 utilized CEA, <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b28">29</ref> 6 used CUA, <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b29">30</ref> and 3 utilized both CUA and CEA. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b23">24,</ref></s><s xml:id="_fzdYwBW">4,<ref type="bibr" target="#b30">31</ref> A societal perspective was only reported in 2 studies, <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b30">31</ref> and the rest were conducted using a health care system perspective.</s><s xml:id="_BwQS5vA"><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> The types of costs reported in each article were different, with 3 studies reporting direct medical costs only, <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b30">31</ref> 1 reporting only program costs, <ref type="bibr" target="#b19">20</ref> and 12 reporting both <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30</ref> (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vVBpBdb">Cost-Effectiveness Outcomes Outcome Measure</head><p xml:id="_EQSDj6B"><s xml:id="_t7uQMuw">The health outcome measures differed across studies and included cost per QALY in 8 studies, <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref> cost per life-year saved in 3 studies, <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b24">25</ref> cost per 1-mm Hg reduction in BP in 7 studies, <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b28">29</ref> cost per improved BP control in 3 studies, <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b24">25</ref> and cost per qualityadjusted days (QADs) in 1 study. <ref type="bibr" target="#b27">28</ref></s><s xml:id="_7AMQ32H">In 9 studies (4 of which were conducted in the UK, <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b29">30</ref> 2 in the US, <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref> and the rest in Russia, <ref type="bibr" target="#b23">24</ref> Australia, <ref type="bibr" target="#b14">15</ref> and Singapore 31 ), a willingness to pay threshold (WTP) to determine whether an intervention was cost-effective was mentioned.</s><s xml:id="_ETEXabr">A sensitivity analysis was conducted in 15 studies (94%) <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> (Table <ref type="table" target="#tab_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mzbtyy7">Cost-Effective Interventions</head><p xml:id="_FZdxmJe"><s xml:id="_2nf9mUB">Of the 16 identified studies, 9 reported that an at-home BP monitoring intervention (HBPM or ABPM) had an ICER within the WTP thresholds, indicating the intervention as cost-effective compared with clinical UC. <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref> Of the remaining 7, all were studies with time periods ranging from 6 to 24 months. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b15">16,</ref></s><s xml:id="_3WTAysM">6,<ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b28">29</ref> Of the 12 identified studies that compared the cost-effectiveness of HBPM vs UC, 5 (42%) reported the intervention as being cost-effective.</s><s xml:id="_4Dxujbs"><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref> Notably, all 5 of these HBPM interventions included either additional support <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b29">30</ref> or TBC <ref type="bibr" target="#b30">31</ref> alongside HBPM alone.</s><s xml:id="_8gWqwJ9">In the single study that compared HBPM alone vs HBPM with additional support vs UC, HBPM with additional support was the most cost-effective option, with the reported ICER of HBPM alone vs usual care being £3035 and the reported ICER of HBPM alone vs HBPM with additional support being £17 424 at a WTP threshold of £20 000 per QALY gained.</s><s xml:id="_5gEHSce"><ref type="bibr" target="#b12">13</ref>   Abbreviations: CEA, cost-effectiveness analysis; CKD, chronic kidney disease; CUA, cost-utility analysis; NHS, National Health Service; RCT, randomized clinical trial. a Direct medical co</s><s xml:id="_QXYRkQ3">ts were defined as medical-related health costs, such as cost of acute or chronic cardiovascular disease events <ref type="bibr" target="#b29">30</ref> ; medication costs <ref type="bibr" target="#b23">24</ref> ; or inpatient, outpatient, or emergency department visit costs.</s><s xml:id="_WTWVsN4"><ref type="bibr" target="#b24">25</ref> Direct program costs were defined as costs related to the intervention including training, equipment, and office units.</s><s xml:id="_5cWFEyp"><ref type="bibr" target="#b19">20</ref>  The remaining 4 studies compared HBPM alone vs ABPM vs UC, and all 4 reported ABPM as being the most cost-effective intervention over both HBPM alone and usual care.</s><s xml:id="_X2AWQzq"><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref> Of 8 simulation models using a time period of 10 years or more, all 8 reported that either HBPM or ABPM were more cost-effective than UC <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b29">30</ref> (Table <ref type="table" target="#tab_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SNSNDhX">Discussion</head><p xml:id="_ekcNVnm"><s xml:id="_qn6y4zH">This systematic review examined the cost-effectiveness of HBPM in comparison with UC.</s><s xml:id="_FkQraUq">Among the identified studies, approximately 60% determined at-home self-monitoring (HBPM or ABPM) to be cost-effective over usual care, particularly long term.</s><s xml:id="_grqKKKR">HBPM was also found to be cost-effective when combined with additional support or within TBC compared with HBPM alone.</s><s xml:id="_6dJep54">For studies comparing HBPM alone with UC and with ABPM, ABPM was found to be the most cost-effective method.</s></p><p xml:id="_WG98Gqt"><s xml:id="_6dD4vfa">The clinical effectiveness of at-home self-monitoring is well-documented in most of the retrieved studies, even among those that used trial time periods of 6 to 24 months and showed improvements in either BP control or reductions in mean BP levels. <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b30">[31]</ref></s><s xml:id="_FnbwsQJ">]<ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b39">40</ref> However, our findings suggest that at-home BP self-monitoring interventions, particularly ABPM and HBPM with additional support or TBC, exhibit superior incremental gains in the long run compared with UC but may not demonstrate well-justified costs given short-term differential outcomes over periods of 6 to 24 months.</s><s xml:id="_ZYQycFG">This is not surprising given the high upfront fixed costs (ie, equipment, training) to implement an at-home self-monitoring intervention and the clinical course and time required to achieve substantially improved health outcomes and to avoid adverse events related to uncontrolled BP.</s><s xml:id="_j8bpm33">Combined, our findings suggest that clinicians, hospitals, health care systems, third-party payers, and other stakeholders should consider the long-term incremental benefits and improvements in patients' BP, quality of life, and reductions in adverse outcomes, which might well justify both the upfront and longer-term costs of more resource-intensive at-home self-monitoring methods over traditional usual care and at-home self-monitoring only.</s><s xml:id="_rwRd2B4">The documented cost-effectiveness of BP self-monitoring at-home with additional support or TBC aligns with previous studies that conducted reviews and synthesized costs and benefits of self-monitoring methods across various diseases and settings. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b36">37</ref></s><s xml:id="_aMqzPRU">-home self-monitoring, particularly ABPM, might further enable the detection of masked and white-coat hypertension.</s><s xml:id="_Z7RdrVn">These terms refer to the detection of elevated BP in a clinical setting (known as white-coat hypertension) and low BP using HBPM or ABPM, or vice versa (known as masked hypertension). <ref type="bibr" target="#b40">41</ref></s><s xml:id="_GWUyKnq">It is currently estimated that 17.1 million adults in the United States have masked hypertension. <ref type="bibr" target="#b26">27</ref></s><s xml:id="_dCGNjcR">This is crucial because one-time or limited office measurements, despite being the traditional method, may vary considerably due to different techniques and methods used, particularly in the presence of a physician or nurse. <ref type="bibr" target="#b41">42</ref></s><s xml:id="_rcdy9hh">Hence, at-home self-monitoring might be more accurate and allow tailored interventions early on, which are critical to control BP and mitigate the associated risks of masked hypertension or prevent unnecessary treatment uptake due to white-coat hypertension.</s><s xml:id="_yAdQyzA">At-home self-monitoring also has the potential to improve patient and clinician satisfaction, particularly in terms of the convenience of recording and sharing BP measurements from home vs going to the clinic.</s><s xml:id="_9GVy68q">Moreover, self-monitoring at home facilitates easier communication with the health care professional when needed, particularly if coupled with additional behavioral interventions or additional support and resources, which allow patients to receive timely advice during consultations and enable the health care team to gain a better understanding of the patient's condition. <ref type="bibr" target="#b30">31</ref></s><s xml:id="_cZajMsU">This can thereby increase patient motivation to monitor BP, which would consequently improve the care provided by enabling the health care professionals to better tailor their treatment approach and ultimately enhance patient outcomes. <ref type="bibr" target="#b42">43</ref></s><s xml:id="_QazH3xd">though this study was based on a systematic literature search and the findings are reported and synthesized in a robust manner, we note that the detailed comparison of many study results and their generalizability across different perspectives and settings remains challenging, particularly due to high variability and inconsistency in reported costs.</s><s xml:id="_2XWfNem">Almost all the studies included in our review</s></p><p xml:id="_TdZXyYd"><s xml:id="_u6RPdeb">JAMA Network Open | Health Informatics Economic Evaluation of BP Monitoring Techniques in Patients With Hypertension JAMA Network Open.</s><s xml:id="_MFGF4pV">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_6Zm9v2F">(Reprinted) November 21, 2023 7/11 Downloaded from jamanetwork.com</s><s xml:id="_QsyMwys">by guest on 06/08/2025 did not account for indirect and intangible costs, such as productivity losses or patient out-of-pocket costs.</s><s xml:id="_S2WTRwV">In addition, given the limited number of studies found in this systematic review that used a societal perspective, future work is needed to conduct cost-effectiveness analyses and evaluations across the various types of BP measurement methods from the societal perspective and incorporate</s></p><p xml:id="_mHJnPcn"><s xml:id="_2gSC6Gf">indirect and intangible patient-level costs.</s><s xml:id="_FBW7UMt">Including such costs might significantly affect the incremental cost differences across competing alternatives and thus findings and future recommendations.</s><s xml:id="_MSgvKxE">Along these lines, we did not find any studies comparing ABPM with HBPM with additional support or TBC-all 3 of which were found to be more cost-effective than UC and HBPM alone in separate analyses.</s><s xml:id="_WR5vUZT">Future studies might consider conducting cost-effectiveness analyses with such comparisons.</s><s xml:id="_wVaaApT">Finally, we note that patient experiences and preferences related to the differences between various home-based care and monitoring systems vs traditional clinical based care can critically affect patients' adherence and, in turn, prevention, and timely treatment initiation and should thus also be considered when determining the WTP pay for such interventions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Rje422R">Strengths and Limitations</head><p xml:id="_W8dgF7q"><s xml:id="_b8qM2J2">This study has several strengths, including a thorough systematic review, data collection, dual independent review of the processes at all stages, utilizing recommended guidelines for conducting the systematic review, <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b21">22</ref> and the representation of the results in tabular summaries. In </s><s xml:id="_N9MeWdg">ddition, this is the most up-to-date study that systematically gathers and synthesizes the available literature on the cost-effectiveness of at-home self-monitoring for patients with hypertension, to our knowledge.</s></p><p xml:id="_xps9JQX"><s xml:id="_bvSG793">Nevertheless, this study also has some limitations.</s><s xml:id="_CXpXxa8">First, most studies included a single stakeholder perspective and thus might not be generalizable.</s><s xml:id="_TNKbw7U">Second, the reported costs across the studies varied due to the types of cost data being included.</s><s xml:id="_GkQDdj7">The details of types of costs included were not consistently provided, making it challenging to compare findings among different studies.</s></p><p xml:id="_C4XKxa3"><s xml:id="_Cy6K5BN">In addition, most studies utilized different definitions of cost inputs, with medical and program costs defined differently.</s><s xml:id="_Ba76bz7">More research is needed to further evaluate the cost-effectiveness of selfmonitoring BP at home in comparison with usual care using longer time periods with costs reported in consistent and clear manner and across multiple perspectives.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uKNMZpx">Conclusions</head><p xml:id="_Y5dYBsX"><s xml:id="_HZBvtVB">In this systematic review, at-home blood pressure monitoring demonstrated the potential to be costeffective over the long-term in comparison with the more usual clinical patient care.</s><s xml:id="_gQEWwVM">Compared with HBPM alone, ABPM and HBPM with additional support or TBC were also found to be more costeffective.</s><s xml:id="_JdKnVan">Future work is needed to compare these alternatives directly from a cost-effectiveness standpoint and to provide clinicians, stakeholders, and patients with more evidence to prioritize specific home-based BP programs.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_wg9dRdn"><s xml:id="_ZYKppM3">Different BP Measurement Methods</s></p></div></figDesc><table><row><cell>Methods/acronym</cell><cell>Description</cell></row><row><cell>HBPM alone</cell><cell>Patients self-measure BP at home without additional support or interventions</cell></row></table><note xml:id="_Y8jyx6n"><p>HBPM with additional support</p><p><s xml:id="_ks28bGu">Patients self-measure BP at home with basic additional resources or support HBPM within TBC Patients self-measure BP at home within a TBC approach, involving more intensive efforts and often combined with other behavioral interventions ABPM Patients' blood pressure measured continuously at home over a 24-h period UC Traditional patient BP measurements at the clinical setting Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; HBPM, home blood pressure monitoring; TBC, team-based care; UC, usual care.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_rEJvv3A"><s xml:id="_85qQw59">General Characteristics of the Identified Articles</s></p></div></figDesc><table><row><cell>Direct medical costs/</cell><cell>direct program costs a</cell><cell>Yes/yes</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>No/yes</cell><cell></cell><cell>Yes/no</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>Yes/yes</cell><cell></cell><cell>Yes/no</cell><cell>Yes/yes</cell><cell>Yes/yes</cell><cell>Yes/yes</cell><cell>Yes/no</cell></row><row><cell></cell><cell>Year of unit costs</cell><cell>2015-2016</cell><cell></cell><cell>2008</cell><cell></cell><cell>2009</cell><cell></cell><cell>2008-2009</cell><cell></cell><cell>2009-2010</cell><cell></cell><cell>2018</cell><cell></cell><cell>2007</cell><cell></cell><cell>2009-2010</cell><cell></cell><cell></cell><cell>2009</cell><cell></cell><cell>2009-2010</cell><cell></cell><cell>2021</cell><cell></cell><cell>2017</cell><cell>2019-2020</cell><cell>2001-2002</cell><cell>2011-2012</cell><cell>2018</cell></row><row><cell></cell><cell>CEA or CUA Perspective</cell><cell>CUA NHS and Personal Social</cell><cell>Services</cell><cell>CEA Societal</cell><cell></cell><cell>CEA Health care</cell><cell></cell><cell>CEA Health care</cell><cell></cell><cell>CUA Health care</cell><cell></cell><cell>Both Ministry of Health of the</cell><cell>Russian Federation</cell><cell>CEA Health care</cell><cell></cell><cell>CEA NHS</cell><cell></cell><cell></cell><cell>CEA Health care</cell><cell></cell><cell>CUA NHS and Personal</cell><cell>Social Service</cell><cell>CUA Health care</cell><cell></cell><cell>CUA Health care</cell><cell>Both Australian government</cell><cell>CEA Health care</cell><cell>CUA NHS and Personal</cell><cell>Social Service</cell><cell>Both Societal</cell></row><row><cell></cell><cell>Time horizon</cell><cell>65 y</cell><cell></cell><cell>24 mo</cell><cell></cell><cell>12 mo</cell><cell></cell><cell>18 mo</cell><cell></cell><cell>35 y</cell><cell></cell><cell>10 y</cell><cell></cell><cell>6 mo</cell><cell></cell><cell>6 mo</cell><cell></cell><cell></cell><cell>6 mo</cell><cell></cell><cell>60 y</cell><cell></cell><cell>Until patients reach the</cell><cell>age of 89 y or death</cell><cell>Until patients reach the</cell><cell>age of 85 y</cell><cell>Lifetime</cell><cell>12 mo</cell><cell>30 y</cell><cell>6 mo</cell></row><row><cell></cell><cell>Method</cell><cell>Markov model</cell><cell></cell><cell>2 × 2 Factorial design</cell><cell></cell><cell>3-Group RCT</cell><cell></cell><cell>2-Group cluster RCT</cell><cell></cell><cell>Markov model</cell><cell></cell><cell>Markov model</cell><cell></cell><cell>Unblinded RCT</cell><cell></cell><cell>Pragmatic, prospective, parallel-</cell><cell>group RCT with blinded outcome</cell><cell>assessments</cell><cell>Pragmatic RCT</cell><cell></cell><cell>Markov model</cell><cell></cell><cell>Microsimulation model</cell><cell></cell><cell>Markov model</cell><cell>Markov model</cell><cell>Unblinded RCT</cell><cell>Markov model</cell><cell>Open-label, quasi-experimental</cell><cell>study</cell></row><row><cell></cell><cell>Eligibility diagnosis</cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell></cell><cell>Hypertension</cell><cell>Hypertension</cell><cell>Hypertension</cell><cell>Hypertension with diabetes</cell><cell>or CKD and/or previous</cell><cell>cardiovascular disease</cell><cell>Hypertension or</cell><cell>hypertension with</cell><cell>hyperlipidemia</cell></row><row><cell></cell><cell>Country</cell><cell>UK</cell><cell></cell><cell>US</cell><cell></cell><cell>US</cell><cell></cell><cell>US</cell><cell></cell><cell>UK</cell><cell></cell><cell>Russia</cell><cell></cell><cell>Denmark</cell><cell></cell><cell>UK</cell><cell></cell><cell></cell><cell>US</cell><cell></cell><cell>UK</cell><cell></cell><cell>US</cell><cell></cell><cell>US</cell><cell>Australia</cell><cell>UK</cell><cell>UK</cell><cell>Singapore</cell></row><row><cell></cell><cell>Source</cell><cell>McManus et al, 35 2018;</cell><cell>Monahan et al, 13 2019</cell><cell>Bosworth et al, 36 2008;</cell><cell>Reed et al, 16 2010</cell><cell>Green et al, 18 2008;</cell><cell>Fishman et al, 20 2013</cell><cell>Margolis et al, 19 2013;</cell><cell>Dehmer et al, 14 2018</cell><cell>McManus et al, 33 2010;</cell><cell>Kaambwa et al, 23 2014</cell><cell>Ionov et al, 24 2021</cell><cell></cell><cell>Madsen et al, 34 2008;</cell><cell>Madsen et al, 6 2011</cell><cell>McKinstry et al, 21 2013</cell><cell></cell><cell></cell><cell>Magid et al, 17 2013;</cell><cell>Billups et al, 25 2014</cell><cell>Lovibond et al, 26 2011</cell><cell></cell><cell>Green et al, 27 2022</cell><cell></cell><cell>Beyhaghi and Viera, 28 2019</cell><cell>Shah et al, 15 2023</cell><cell>McManus et al, 29 2005</cell><cell>McManus et al, 32 2014;</cell><cell>Penaloza-Ramos et al, 30</cell><cell>2016</cell><cell>Teo et al, 31 2021</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_g2TMrJc"><s xml:id="_hmX6tbg">Analysis Methods and Outcome Measures in Cost Analysis Studies</s></p></div></figDesc><table><row><cell>Sensitivity Probability</cell><cell>analysis ICER per intervention(s) per outcome measure of CE per WTP</cell><cell>Yes HBPM alone vs UC: £3035; HBPM with additional support vs HBPM HBPM alone: 38%;</cell><cell>alone: £17 424 HBPM with additional</cell><cell>support: 51%</cell><cell>Yes HBPM with TBC vs UC: cost per 1-mm Hg SBP reduction, $107 in NR</cell><cell>direct medical costs and $297 when including patient time costs; cost</cell><cell>per 1-mm Hg DBP reduction, NR; cost per life-year gained: $4169</cell><cell>Yes HBPM with additional support vs UC: cost per person achieving BP NR</cell><cell>control, no significant difference; cost per 1-mm Hg SBP reduction,</cell><cell>$23.8 (95% CI, $21.3 to $26.2); cost per 1-mm Hg DBP reduction, no</cell><cell>significant difference; cost per change in life expectancy, no</cell><cell>significant difference; HBPM within TBC vs HBPM with additional</cell><cell>support: cost per person achieving BP control, $16.7 (95% CI, $15.4</cell><cell>to $17.9); cost per 1-mm Hg SBP reduction, $65.3 (95% CI, $59.9 tp</cell><cell>$70.7); cost per 1-mm Hg DBP reduction, $114.8 (95% CI, $111.9 to</cell><cell>$117.7); cost per change in life expectancy among males, $1850</cell><cell>(95% CI, $1635.7 to $2064.2); among females, $2220 (95% CI,</cell><cell>$1745.1 to $2694.9)</cell><cell>Yes Cost per person achieving BP control, $7337; cost per 1-mm Hg SBP NR</cell><cell>reduction, $139; cost per 1-mm Hg DBP reduction, $265</cell><cell></cell><cell>Yes Men, £1,624; women, £4923 99% of iterations for</cell><cell>men and women</cell><cell></cell><cell>Yes Cost per 1-mm Hg BP reduction, 731.1 RUB; cost per QALY, 275 179 76%</cell><cell>RUB</cell><cell>Yes Cost per 1-mm Hg reduction in SBP, 256 DKK (95% CI, -860 to 4544 NR</cell><cell>DKK); in DBP, 655 DKK (95% CI, -674 to 69 315 DKK)</cell><cell>Yes £25.6 (95% CI, £16.1 to £46.7) NR</cell><cell></cell><cell>Yes Cost per 1-mm Hg BP reduction, $20.5; cost per person achieving BP NR</cell><cell>control; $1331; cost per life-year gained, $3330</cell><cell></cell><cell></cell><cell>Yes ABPM dominates UC and HBPM alone ABPM in almost all</cell><cell>iterations</cell><cell>Yes UC and HBPM alone vs UC, UC dominates; UC and ABPM vs UC, At WTP of $50 000, UC</cell><cell>$85 164 dominant; at WTP of</cell><cell>$100 000, ABPM:</cell><cell>66%; at WTP of</cell><cell>$150 000, ABPM:</cell><cell>89.5%</cell><cell>Yes HBPM alone vs UC: UC dominates; ABPM vs HBPM alone: ABPM ABPM in almost all</cell><cell>dominates iterations in men and</cell><cell>women &lt;80 y of age</cell><cell>Yes HBPM alone vs UC, HBPM alone dominates both outcomes; ABPM vs ABPM in almost all</cell><cell>HBPM alone, ABPM dominates both outcomes iterations</cell><cell></cell><cell>Yes £5.1 (95% CI, -£7.2 to £19.1) NR</cell><cell>Yes Dominates 99%</cell><cell>No Cost per person achieving BP control, S$468.6; cost per QALY, NR</cell><cell>S$23 935.1</cell><cell>systolic blood pressure; QAD, quality-adjusted day; QALY, quality-adjusted life-year; TBC, team-based care; UC,</cell><cell>usual care; WTP, willingness-to-pay threshold.</cell></row><row><cell></cell><cell>Source Control Intervention(s) Outcome measure WTP threshold</cell><cell>McManus et al, 35 UC HBPM alone; HBPM Cost per QALY £20 000/QALY</cell><cell>2018; Monahan with additional support</cell><cell>et al, 13 2019</cell><cell>Bosworth et al, 36 UC HBPM; TBC; HBPM Cost per 1-mm Hg BP NR</cell><cell>2008; Reed et al, 16 within TBC reduction; cost per life-</cell><cell>2010 year gained</cell><cell>Green et al, 18 2008; UC HBPM with additional Cost per person achieving NR</cell><cell>Fishman et al, 20 2013 support; HBPM within BP control; cost per 1-mm</cell><cell>TBC Hg BP reduction; cost per</cell><cell>change in life expectancy</cell><cell>achieved through greater</cell><cell>control of hypertension</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Margolis et al, 19 UC HBPM within TBC Cost per person achieving NR</cell><cell>2013; Dehmer BP control; cost per 1-mm</cell><cell>et al, 14 2018 Hg BP reduction</cell><cell>McManus et al, 33 UC HBPM with additional Cost per QALY £20 000 to</cell><cell>2010; Kaambwa support £30 000/QALY</cell><cell>et al, 23 2014</cell><cell>Ionov et al, 24 2021 UC HBPM with additional Cost per 1-mm Hg BP 300 000 RUB/1-mm Hg</cell><cell>support reduction; cost per QALY decrease</cell><cell>Madsen et al, 34 2008; UC HBPM with additional Cost per 1-mm Hg BP NR</cell><cell>Madsen et al, 6 2011 support reduction</cell><cell>McKinstry et al, 21 UC HBPM with additional Cost per 1-mm Hg BP NR</cell><cell>2013 support reduction</cell><cell>Magid et al, 17 2013; UC HBPM within TBC Cost per 1-mm Hg BP NR</cell><cell>Billups et al, 25 2014 reduction; cost per person</cell><cell>achieving BP control; cost</cell><cell>per life-year gained</cell><cell>Lovibond et al, 26 UC HBPM alone; ABPM Cost per QALY £20 000 to</cell><cell>2011 £30 000/QALY</cell><cell>Green et al, 27 2022 UC UC and HBPM alone; UC Cost per QALY $50 000 to</cell><cell>and ABPM $150 000/QALY</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Beyhaghi and Viera, 28 UC HBPM alone; ABPM Cost per QAD $50 000/QALY</cell><cell>2019</cell><cell></cell><cell>Shah et al, 15 2023 UC HBPM alone; ABPM Cost per QALY; cost per Cost per QALY, A$50 000;</cell><cell>life-year gained cost per life-year gained,</cell><cell>A$28 003</cell><cell>McManus et al, 29 UC HBPM alone and self-Cost per 1-mm Hg BP NR</cell><cell>2005 measured BP at GP reduction</cell><cell>McManus et al, 32 UC HBPM with additional Cost per QALY £20 000 to</cell><cell>2014; Penaloza-support £30 000/QALY</cell><cell>Ramos et al, 30 2016</cell><cell>Teo et al, 31 2021 UC HBPM within TBC Cost per person achieving &lt;1 GDP per capita per</cell><cell>BP control; cost per QALY QALY; GDP assumed</cell><cell>S$78 000 or S$58 000</cell><cell>Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; CE, cost-effective; DBP,</cell><cell>diastolic blood pressure; GP, general practitioner; HBPM, home blood pressure monitoring; NR, not reported; SBP,</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_3mqr2h5"><s xml:id="_T89nawp">JAMA Network Open.</s><s xml:id="_mpUcEEY">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_cckzgT2">(Reprinted) November 21, 2023 4/11 Downloaded from jamanetwork.com</s><s xml:id="_nHtfqpk">by guest on 06/08/2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_wT3jzU7"><s xml:id="_Mr5wbGp">JAMA Network Open.</s><s xml:id="_ksCg8Rh">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_uEQxh3Z">(Reprinted) November 21, 2023 5/11 Downloaded from jamanetwork.com</s><s xml:id="_b5xu5cc">by guest on 06/08/2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_zkgvfs6"><s xml:id="_AvNF9x8">JAMA Network Open.</s><s xml:id="_FdWSb8c">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_NygugM5">(Reprinted) November 21, 2023 6/11 Downloaded from jamanetwork.com</s><s xml:id="_hgZb2vS">by guest on 06/08/2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_rX8FeSj"><s xml:id="_2j6gVeG">JAMA Network Open.</s><s xml:id="_mpNWhq8">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_tDXYThg">(Reprinted) November 21, 2023 9/11 Downloaded from jamanetwork.com</s><s xml:id="_3aceQuS">by guest on 06/08/2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_mGhuSrX"><s xml:id="_U9tzJdg">JAMA Network Open.</s><s xml:id="_YKcaNM4">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_auCu6ch">(Reprinted) November 21, 2023 10/11 Downloaded from jamanetwork.com</s><s xml:id="_sYkD3rR">by guest on 06/08/2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_kSnbzQR"><s xml:id="_D9bWkzy">JAMA Network Open.</s><s xml:id="_47J8mRN">2023;6(11):e2344372. doi:10.1001/jamanetworkopen.2023.44372</s><s xml:id="_uwDAqY7">(Reprinted) November 21, 2023 11/11 Downloaded from jamanetwork.com</s><s xml:id="_R42PfSa">by guest on 06/08/2025</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZAD6kDY">ARTICLE INFORMATION</head><p xml:id="_5bAamck"><s xml:id="_PdnQ7QM">Author Contributions: Ms Hayek and Dr Giannouchos had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</s></p><p xml:id="_DgUYY5v"><s xml:id="_jy8punA">Concept and design: Hayek, Giannouchos, Lawley.</s></p><p xml:id="_TzP73e8"><s xml:id="_s4gGaBs">Acquisition, analysis, or interpretation of data: Hayek, Giannouchos, Kum.</s></p><p xml:id="_cnqweC6"><s xml:id="_b6TTkKx">Drafting of the manuscript: Hayek, Giannouchos, Kum.</s></p><p xml:id="_XTTBJVu"><s xml:id="_vB9wsyC">Critical review of the manuscript for important intellectual content: All authors.</s></p><p xml:id="_g44AN3H"><s xml:id="_y53vvFq">Obtained funding: Lawley, Kum.</s></p><p xml:id="_cXUgUQN"><s xml:id="_75bYZEZ">Administrative, technical, or material support: Giannouchos, Kum.</s><s xml:id="_e2GcAbV">Supervision: Giannouchos, Lawley, Kum.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aWTEyGa">Conflict of Interest Disclosures:</head><p xml:id="_HS2QzhH"><s xml:id="_KGT8Pzq">Dr Lawley reported receiving grants from National Science Foundation during the conduct of the study.</s><s xml:id="_gCxg8n8">No other disclosures were reported.</s></p><p xml:id="_NF2rhDZ"><s xml:id="_9WbHFTk">Funding/Support: These projects were supported by the Texas A&amp;M President's Office X-grant initiative (Drs Lawley and Kum), National Science Foundation PATHS-UP (Drs Lawley and Kum), and Population Informatics Lab (Dr Kum).</s></p><p xml:id="_2ZzfgCY"><s xml:id="_qJXsMf6">Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</s></p><p xml:id="_XW849eX"><s xml:id="_7Ua6XN2">Data Sharing Statement: See Supplement 2.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<idno type="DOI">10.1097/00004872-200311000-00002</idno>
		<ptr target="https://www.who.int/news-room/fact-sheets/detail/hypertension" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Fcjysw9">Hypertension</title>
		<imprint>
			<date type="published" when="2023-05-21">May 21, 2023</date>
			<publisher>World Health Organization</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Hypertension. Accessed May 21, 2023. https://www.who.int/news-room/fact-sheets/ detail/hypertension</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_gbedhAw">International Society of Hypertension. The global cost of nonoptimal blood pressure</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Gaziano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bitton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Weinstein</surname></persName>
		</author>
		<idno type="DOI">10.1097/hjh.0b013e32832a9ba3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xqGmc6Q">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1472" to="1477" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gaziano TA, Bitton A, Anand S, Weinstein MC; International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27(7):1472-1477. doi:10.1097/HJH.0b013e32832a9ba3</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_kVW7vNF">Home blood pressure management and improved blood pressure control: results from a randomized controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Olsen</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/archinternmed.2011.276&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamanetworkopen.2023.44372</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_grXFeBm">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1173" to="1180" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosworth HB, Powers BJ, Olsen MK, et al. Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med. 2011;171(13):1173-1180. doi:10.1001/ archinternmed.2011.276</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_Pwwq3w7">Economic evaluations of remote patient monitoring for chronic disease: a systematic review</title>
		<author>
			<persName><forename type="first">De</forename><surname>Guzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Snoswell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Caffery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.jval.2021.12.001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jRPa4w9">Value Health</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="897" to="913" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">De Guzman KR, Snoswell CL, Taylor ML, Gray LC, Caffery LJ. Economic evaluations of remote patient monitoring for chronic disease: a systematic review. Value Health. 2022;25(6):897-913. doi:10.1016/j.jval.2021. 12.001</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_qv2QTSa">Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003-2014</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Kirkland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heincelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Bishu</surname></persName>
		</author>
		<idno type="DOI">10.1161/jaha.118.008731</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pPuTphb">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">8731</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kirkland EB, Heincelman M, Bishu KG, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003-2014. J Am Heart Assoc. 2018;7(11):e008731. doi:10.1161/JAHA.118. 008731</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_H7fHyR8">Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Pedersen</surname></persName>
		</author>
		<idno type="DOI">10.3109/08037051.2010.532306</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rPsPS6P">Blood Press</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="117" to="125" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Madsen LB, Christiansen T, Kirkegaard P, Pedersen EB. Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial. Blood Press. 2011;20(2):117-125. doi:10.3109/08037051.2010. 532306</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_ej9JYWP">Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Uhlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Kitsios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Balk</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-159-3-201308060-00008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bVtbrhx">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="185" to="194" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3):185-194. doi:10.7326/0003- 4819-159-3-201308060-00008</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_HhnNHn8">Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Omboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gazzola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Carabelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Parati</surname></persName>
		</author>
		<idno type="DOI">10.1097/hjh.0b013e32835ca8dd</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fVggz4H">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="455" to="467" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455-467. doi:10.1097/ HJH.0b013e32835ca8dd</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_jtgnVcR">Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Basu</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12195&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamanetworkopen.2023.44372</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K9FahBZ">JAMA</title>
		<imprint>
			<biblScope unit="volume">316</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1093" to="1103" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016; 316(10):1093-1103. doi:10.1001/jama.2016.12195</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_qRSZyd8">Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement</title>
		<author>
			<persName><forename type="first">D</forename><surname>Husereau</surname></persName>
			<affiliation>
				<orgName type="collaboration">CHEERS Task Force</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Drummond</surname></persName>
			<affiliation>
				<orgName type="collaboration">CHEERS Task Force</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Petrou</surname></persName>
			<affiliation>
				<orgName type="collaboration">CHEERS Task Force</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1136/bmj.f1049</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KnDk8HF">BMJ</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page">1049</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Husereau D, Drummond M, Petrou S, et al; CHEERS Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ. 2013;346:f1049. doi:10.1136/bmj.f1049</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main" xml:id="_6Tq7qeb">Cost-Effectiveness in Health and Medicine</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Russel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Ganiats</surname></persName>
		</author>
		<idno type="DOI">10.1093/acprof:oso/9780190492939.001.0001</idno>
		<imprint>
			<date type="published" when="2016">2016</date>
			<publisher>Oxford University Press</publisher>
		</imprint>
	</monogr>
	<note>2nd ed</note>
	<note type="raw_reference">Neumann PJ, Sanders GD, Russel LB, Siegel JE, Ganiats TG. Cost-Effectiveness in Health and Medicine. 2nd ed. Oxford University Press; 2016. doi:10.1093/acprof:oso/9780190492939.001.0001</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_XmPhZdY">The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mckenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bossuyt</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pmed.1003583</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_H4sJYJD">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">1003583</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. doi:10.1371/journal.pmed.1003583</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_QeEBSv8">Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Monahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nickless</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.118.12415</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vdXmG5x">Hypertension</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1231" to="1239" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Monahan M, Jowett S, Nickless A, et al. Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension. 2019;73(6):1231-1239. doi:10. 1161/HYPERTENSIONAHA.118.12415</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_nqAGccV">Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Dehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Maciosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Trower</surname></persName>
		</author>
		<idno type="DOI">10.1002/jac5.1001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Bht2Swj">J Am Coll Clin Pharm</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="21" to="30" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dehmer SP, Maciosek MV, Trower NK, et al. Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. J Am Coll Clin Pharm. 2018;1(1):21-30. doi:10.1002/jac5.1001</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_VPPCJ8F">Cost effectiveness of ambulatory blood pressure monitoring compared with home or clinic blood pressure monitoring for diagnosing hypertension in Australia</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Willson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Agresta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Morton</surname></persName>
		</author>
		<idno type="DOI">10.1007/s41669-022-00364-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NF4seKG">Pharmacoecon Open</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="49" to="62" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shah KK, Willson M, Agresta B, Morton RL. Cost effectiveness of ambulatory blood pressure monitoring compared with home or clinic blood pressure monitoring for diagnosing hypertension in Australia. Pharmacoecon Open. 2023;7:49-62. doi:10.1007/s41669-022-00364-0</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_6HvtxtM">Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Z</forename><surname>Oddone</surname></persName>
		</author>
		<idno type="DOI">10.1038/ajh.2009.215</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5g2KNKr">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="142" to="148" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Reed SD, Li Y, Oddone EZ, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens. 2010;23(2):142-148. doi: 10.1038/ajh.2009.215</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_PAhcUGt">A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Magid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Billups</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Kroner</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.112.968172</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Xk2tTSA">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="157" to="163" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013;6(2):157-163. doi:10.1161/CIRCOUTCOMES.112.968172</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_tvdZBkP">Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ralston</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.299.24.2857&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamanetworkopen.2023.44372</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UBPTcn5">JAMA</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="2857" to="2867" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857-2867. doi:10.1001/jama.299.24.2857</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_dKahpD3">Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Asche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Bergdall</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2013.6549&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamanetworkopen.2023.44372</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fYtEnWa">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="46" to="56" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46-56. doi:10.1001/ jama.2013.6549</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_tHFjJpA">Improving BP control through electronic communications: an economic evaluation</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Fishman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Anderson</surname></persName>
		</author>
		<idno type="DOI">10.37765/ajmc.2024.89518</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C4dv6WS">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="709" to="716" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fishman PA, Cook AJ, Anderson ML, et al. Improving BP control through electronic communications: an economic evaluation. Am J Manag Care. 2013;19(9):709-716.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_8CH7wQf">Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mckinstry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wild</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.f3030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GAvdAuD">BMJ</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page">3030</biblScope>
			<date type="published" when="2013">2013. 7913</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McKinstry B, Hanley J, Wild S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ. 2013;346(7913):f3030. doi:10.1136/ bmj.f3030</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main" xml:id="_2W5kdsq">Critical appraisal tools</title>
		<idno type="DOI">10.7717/peerj.18274/supp-5</idno>
		<ptr target="https://jbi.global/critical-appraisal-tools" />
		<imprint>
			<date type="published" when="2023-03-25">March 25, 2023</date>
			<publisher>JBI</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Critical appraisal tools. JBI. Accessed March 25, 2023. https://jbi.global/critical-appraisal-tools</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_zDsky4a">Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Kaambwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487313501886</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BmeUksX">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1517" to="1530" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kaambwa B, Bryan S, Jowett S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517-1530. doi:10.1177/ 2047487313501886</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_Uz3BzbF">Value-based approach to blood pressure telemonitoring and remote counseling in hypertensive patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Ionov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">V</forename><surname>Zhukova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Yudina</surname></persName>
		</author>
		<idno type="DOI">10.1080/08037051.2020.1813015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jTwK4Fj">Blood Press</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="20" to="30" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ionov MV, Zhukova OV, Yudina YS, et al. Value-based approach to blood pressure telemonitoring and remote counseling in hypertensive patients. Blood Press. 2021;30(1):20-30. doi:10.1080/08037051.2020.1813015</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_Fau2Emm">Cost-effectiveness evaluation of a home blood pressure monitoring program</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Billups</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Magid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wDvvkYc">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="380" to="e387" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Billups SJ, Moore LR, Olson KL, Magid DJ. Cost-effectiveness evaluation of a home blood pressure monitoring program. Am J Manag Care. 2014;20(9):e380-e387.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_guVeGzP">Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lovibond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Barton</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(11)61184-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k9vkYHm">Lancet</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="1219" to="1230" />
			<date type="published" when="2011">2011. 9798</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378(9798):1219-1230. doi:10.1016/S0140-6736(11)61184-7</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_V9mpSVa">Cost-effectiveness of masked hypertension screening and treatment in US adults with suspected masked hypertension: a simulation study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shimbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Schwartz</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajh/hpac071</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dD2Wczj">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="752" to="762" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Green MB, Shimbo D, Schwartz JE, et al. Cost-effectiveness of masked hypertension screening and treatment in US adults with suspected masked hypertension: a simulation study. Am J Hypertens. 2022;35(8):752-762. doi: 10.1093/ajh/hpac071</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_ur9QFaG">Comparative cost-effectiveness of clinic, home, or ambulatory blood pressure measurement for hypertension diagnosis in US adults</title>
		<author>
			<persName><forename type="first">H</forename><surname>Beyhaghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Viera</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.118.11715</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g2AzRXs">Hypertension</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="121" to="131" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beyhaghi H, Viera AJ. Comparative cost-effectiveness of clinic, home, or ambulatory blood pressure measurement for hypertension diagnosis in US adults. Hypertension. 2019;73(1):121-131. doi:10.1161/ HYPERTENSIONAHA.118.11715</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_BJUcEXU">Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roalfe</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.38558.393669.e0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GuB7n85">BMJ</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="issue">7515</biblScope>
			<biblScope unit="page" from="493" to="496" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McManus RJ, Mant J, Roalfe A, et al. Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ. 2005;331(7515):493-496. doi:10.1136/bmj.38558.393669.E0</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_tcqq6TZ">Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR)</title>
		<author>
			<persName><forename type="first">Penaloza-Ramos</forename><surname>Mc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487315618784</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dE68m5D">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="902" to="912" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Penaloza-Ramos MC, Jowett S, Mant J, et al. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR). Eur J Prev Cardiol. 2016;23(9):902-912. doi:10.1177/2047487315618784</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_zWdqbzD">Effects of technology-enabled blood pressure monitoring in primary care: A quasi-experimental trial</title>
		<author>
			<persName><forename type="first">Vhy</forename><surname>Teo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Teo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Burkill</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x211031780</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Qx5K3Fz">J Telemed Telecare</title>
		<imprint>
			<date type="published" when="2021-07-30">July 30, 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Teo VHY, Teo SH, Burkill SM, et al. Effects of technology-enabled blood pressure monitoring in primary care: A quasi-experimental trial. J Telemed Telecare. Published online July 30, 2021. doi:10.1177/1357633X211031780</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_s8YVp7T">Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Haque</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.10057&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamanetworkopen.2023.44372</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Gtgjy64">JAMA</title>
		<imprint>
			<biblScope unit="volume">312</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="799" to="808" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799-808. doi:10.1001/jama.2014.10057</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_mUEKRmb">Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Bray</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(10)60964-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pbPxmYB">Lancet</title>
		<imprint>
			<biblScope unit="volume">376</biblScope>
			<biblScope unit="page" from="163" to="172" />
			<date type="published" when="2010">2010. 9736</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163-172. doi:10.1016/S0140-6736(10) 60964-6</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_h2ZgFVq">Blood pressure control during telemonitoring of home blood pressure: a randomized controlled trial during 6 months</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Pedersen</surname></persName>
		</author>
		<idno type="DOI">10.1080/08037050801915468</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mwm2RZm">Blood Press</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="78" to="86" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Madsen LB, Kirkegaard P, Pedersen EB. Blood pressure control during telemonitoring of home blood pressure: a randomized controlled trial during 6 months. Blood Press. 2008;17(2):78-86. doi:10.1080/ 08037050801915468</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_2NcWjyA">TASMINH4 investigators. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Franssen</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(18)30309-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yYxRxFR">Lancet</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="issue">10124</biblScope>
			<biblScope unit="page" from="949" to="959" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McManus RJ, Mant J, Franssen M, et al; TASMINH4 investigators. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949-959. doi:10.1016/S0140-6736(18)30309-X</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_uhqGMMX">Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neary</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2007.11.014</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_q2FtKDK">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="338" to="347" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosworth HB, Olsen MK, Neary A, et al. Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008; 70(3):338-347. doi:10.1016/j.pec.2007.11.014</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_u6fxxzk">Economics of selfmeasured blood pressure monitoring: a community guide systematic review</title>
		<author>
			<persName><forename type="first">V</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Chattopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Proia</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2017.03.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_beyvfQU">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="105" to="e113" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jacob V, Chattopadhyay SK, Proia KK, et al; Community Preventive Services Task Force. Economics of self- measured blood pressure monitoring: a community guide systematic review. Am J Prev Med. 2017;53(3): e105-e113. doi:10.1016/j.amepre.2017.03.002</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_QJtTZPZ">Hypertension Canada&apos;s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Mcbrien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sapir-Pichhadze</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cjca.2020.02.086</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yWh4Vhb">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="596" to="624" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada&apos;s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36(5):596-624. doi:10.1016/j.cjca.2020.02.086</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_Mx4jgR8">ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
		<idno type="DOI">10.1161/hyp.0000000000000065</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HmY4vzn">Hypertension</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="13" to="e115" />
			<date type="published" when="2017">2017. 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115. doi:10.1161/HYP.0000000000000065</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_qgFZVZT">Predicting out-of-office blood pressure in the clinic for the diagnosis of hypertension in primary care: an economic evaluation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Monahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lovibond</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.117.10244</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2k6AuVD">Hypertension</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="250" to="261" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Monahan M, Jowett S, Lovibond K, et al; PROOF-BP investigators. Predicting out-of-office blood pressure in the clinic for the diagnosis of hypertension in primary care: an economic evaluation. Hypertension. 2018;71(2): 250-261. doi:10.1161/HYPERTENSIONAHA.117.10244</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_SsTkE2J">European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement</title>
		<author>
			<persName><forename type="first">E</forename><surname>O'brien</surname></persName>
			<affiliation>
				<orgName type="collaboration">European Society of Hypertension Working Group on Blood Pressure Monitoring</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Asmar</surname></persName>
			<affiliation>
				<orgName type="collaboration">European Society of Hypertension Working Group on Blood Pressure Monitoring</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beilin</surname></persName>
			<affiliation>
				<orgName type="collaboration">European Society of Hypertension Working Group on Blood Pressure Monitoring</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1097/00004872-200305000-00001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MKxGuU2">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="821" to="848" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">O&apos;Brien E, Asmar R, Beilin L, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21(5):821-848. doi:10.1097/00004872-200305000-00001</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_nGuvRmA">Diagnosis of white coat hypertension by ambulatory blood pressure monitoring</title>
		<author>
			<persName><forename type="first">P</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Atkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.34.2.267</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZP4DjmW">Hypertension</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="267" to="272" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Owens P, Atkins N, O&apos;Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension. 1999;34(2):267-272. doi:10.1161/01.HYP.34.2.267</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_Jcm34W2">Home blood pressure monitoring: effect on use of medical services and medical care costs</title>
		<author>
			<persName><forename type="first">K</forename><surname>Soghikian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Casper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Fireman</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005650-199209000-00009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Xj6845M">Med Care</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="855" to="865" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Soghikian K, Casper SM, Fireman BH, et al. Home blood pressure monitoring: effect on use of medical services and medical care costs. Med Care. 1992;30(9):855-865. doi:10.1097/00005650-199209000-00009 SUPPLEMENT 1. eTable</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_k6UFt77">Search Strategy Results eTable 2. Additional Information on Article Selection and Quality Assessment eReferences</title>
		<idno type="DOI">10.7717/peerj.13664/supp-1</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_DJ78AAA">Search Strategy eFigure</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
		</imprint>
	</monogr>
	<note>Data Sharing Statement</note>
	<note type="raw_reference">Search Strategy eFigure. Search Strategy Results eTable 2. Additional Information on Article Selection and Quality Assessment eReferences. SUPPLEMENT 2. Data Sharing Statement</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
